SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).
Clin Transl Oncol
; 26(11): 2856-2865, 2024 Nov.
Article
in En
| MEDLINE
| ID: mdl-38662171
ABSTRACT
The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available.
Key words
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Neoplasm Grading
/
Glioma
Limits:
Humans
Language:
En
Journal:
Clin Transl Oncol
Year:
2024
Document type:
Article